Immediate and long-term consequences of COVID-19 infections for the development of neurological disease
- PMID: 32498691
- PMCID: PMC7271826
- DOI: 10.1186/s13195-020-00640-3
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease
Abstract
Increasing evidence suggests that infection with Sars-CoV-2 causes neurological deficits in a substantial proportion of affected patients. While these symptoms arise acutely during the course of infection, less is known about the possible long-term consequences for the brain. Severely affected COVID-19 cases experience high levels of proinflammatory cytokines and acute respiratory dysfunction and often require assisted ventilation. All these factors have been suggested to cause cognitive decline. Pathogenetically, this may result from direct negative effects of the immune reaction, acceleration or aggravation of pre-existing cognitive deficits, or de novo induction of a neurodegenerative disease. This article summarizes the current understanding of neurological symptoms of COVID-19 and hypothesizes that affected patients may be at higher risk of developing cognitive decline after overcoming the primary COVID-19 infection. A structured prospective evaluation should analyze the likelihood, time course, and severity of cognitive impairment following the COVID-19 pandemic.
Keywords: Cognition; Cytokine; Decline; NLRP3 inflammasome; Neurodegeneration; Neuroinflammation; Systemic inflammation.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Seeding Brain Protein Aggregation by SARS-CoV-2 as a Possible Long-Term Complication of COVID-19 Infection.ACS Chem Neurosci. 2020 Nov 18;11(22):3704-3706. doi: 10.1021/acschemneuro.0c00676. Epub 2020 Nov 4. ACS Chem Neurosci. 2020. PMID: 33147014 Review.
-
SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis.ACS Chem Neurosci. 2020 Jul 1;11(13):1887-1899. doi: 10.1021/acschemneuro.0c00251. Epub 2020 Jun 18. ACS Chem Neurosci. 2020. PMID: 32491829 Review.
-
Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?Neurologia (Engl Ed). 2020 May;35(4):245-251. doi: 10.1016/j.nrl.2020.04.002. Epub 2020 Apr 17. Neurologia (Engl Ed). 2020. PMID: 32364119 Free PMC article. Review. English, Spanish.
-
Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19.ACS Chem Neurosci. 2020 Jun 17;11(12):1701-1703. doi: 10.1021/acschemneuro.0c00286. Epub 2020 May 29. ACS Chem Neurosci. 2020. PMID: 32469504
-
Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients.J Neurosci Res. 2020 Dec;98(12):2376-2383. doi: 10.1002/jnr.24717. Epub 2020 Aug 31. J Neurosci Res. 2020. PMID: 32869376 Review.
Cited by
-
Machine learning predictive modeling of the persistence of post-Covid19 disorders: Loss of smell and taste as case studies.Heliyon. 2024 Jul 27;10(15):e35246. doi: 10.1016/j.heliyon.2024.e35246. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170549 Free PMC article.
-
Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies.Front Immunol. 2024 Aug 1;15:1398028. doi: 10.3389/fimmu.2024.1398028. eCollection 2024. Front Immunol. 2024. PMID: 39148725 Free PMC article.
-
Cognitive dysfunctions in the course of SARS‑CoV‑2 virus infection, including NeuroCOVID, frontal syndrome and cytokine storm (Review).Biomed Rep. 2024 May 16;21(1):103. doi: 10.3892/br.2024.1791. eCollection 2024 Jul. Biomed Rep. 2024. PMID: 38800038 Free PMC article. Review.
-
Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach.Diseases. 2024 May 6;12(5):95. doi: 10.3390/diseases12050095. Diseases. 2024. PMID: 38785750 Free PMC article. Review.
-
A Multi-Dimensional Psychiatric Perspective on the Impact of the COVID-19 Pandemic.Psychiatry Clin Psychopharmacol. 2021 Jun 1;31(2):219-225. doi: 10.5152/pcp.2021.21222. eCollection 2021 Jun. Psychiatry Clin Psychopharmacol. 2021. PMID: 38765226 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous